Close Menu

CHICAGO (GenomeWeb) – Genomics England will use Edico Genome's technology to help improve the accuracy and consistency of its analysis of next-generation sequencing data for rare diseases.

As it works to make NGS a standard of care in the UK National Health Service this year, Genomics England has implemented Edico's Dragen Bio-IT platform to address alignment and variant calling of whole-genome sequencing data. Edico made the announcement today at the annual J.P. Morgan Healthcare Conference in San Francisco.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The US Patent and Trademark Office is opening another interference proceeding in the CRISPR patent fight.

There's increasing genetic evidence that a number of ancient hominins may have contributed to the human gene pool, according to Discover's The Crux blog.

The Japan News writes that Japan needs to seize the opportunity to ensure that a wide number of people benefit from personalized cancer treatments.

In Cell this week: messenger RNA expression and translation, RNA localization atlas, and more.